GGrantIndex
Sort

64,565 grants matching drug discovery

Inhaled Aminoglycoside Formulafor Plague and Tularemia

$812,118
Nanotherapeutics, Inc. · R01 · FY2005 · AI

Development of Novel Proteins Synthesis Inhibitors for MDR Tuberculosis

$811,999
Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2020 · AI

Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD

$811,977
Rita Sattler · St. Joseph'S Hospital And Medical Center · R01 · FY2024 · NS

Development of therapeutic candidates for stimulant use disorder using AI-driven platform for focused drug discovery and accelerated development

$811,876
Jyotika Varshney · Verisim Life, Inc. · R42 · FY2025 · DA

Development of Long-acting Cocaine Hydrolase as a Treatment for Cocaine Abuse

$811,835
Chang-Guo Zhan · University Of Kentucky · UH3 · FY2019 · DA

Preclinical assessment of GCPII inhibitors for cognition and tau pathology

$811,824
Amy F.t. Arnsten · Yale University · R01 · FY2020 · AG

Validation of Lens Beta-Amyloid as a Novel Biomarker for Early Detection of Alzheimer's Disease at the Boston University Alzheimer's Disease Research

$811,737
Lee E Goldstein · Boston University Medical Campus · R01 · FY2024 · AG

Nucleocytoplasmic transport: a target for cellular control

$811,719
Michael P Rout · Rockefeller University · U01 · FY2011 · GM

Risk stratification in pulmonary arterial hypertension: Intersection of OMICs and longitudinal phenotypes through the PAH Biobank

$811,691
William C Nichols · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · HL

The Role of AP-1 and Other Transcription Factors in Cancer Cause and Prevention

$811,513
Nancy H. Colburn · Basic Sciences · Z01 · FY2007 · CA

The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression

$811,513
Nancy H. Colburn · Basic Sciences · Z01 · FY2007 · CA

Design And Development Of Experimental Therapeutics

$811,428
Nigel H. Greig · National Institute On Aging · ZIA · FY2019 · AG

Intermembrane transport of lipids and metabolites by mycobacterial MmpL protein complexes

$811,396
Helen I. Zgurskaya · University Of Oklahoma · R01 · FY2025 · AI

Ultrahigh-throughput Identification of Molecular Targets of Natural Products

$811,252
Daojing Wang · Newomics, Inc · R44 · FY2017 · AT

Animal Efficacy and Pharmacometric Modeling Core

$811,125
Isabel Lauren Jackson · University Of Maryland Baltimore · U19 · FY2020 · AI

T Cell Alternative p38 Activation Pathway

$811,121
Jonathan Ashwell · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Bay Area Cancer Target Discovery and Development Network

$811,078
Frank Patrick McCormick · University Of California, San Francisco · U01 · FY2015 · CA

Engineering Multifunctional Nanoparticles

$811,057
Sangeeta N. Bhatia · Massachusetts Institute Of Technology · R01 · FY2009 · CA

MOLECULAR APPROACHES TO DISCOVER MARINE NATURAL PRODUCT

$810,862
University Of California Santa Cruz · U19 · FY2003 · CA

A Community Zebrafish Resource for Modeling GWAS Biology

$810,727
Calum A. Macrae · Brigham And Women'S Hospital · R24 · FY2015 · OD

Prevention of Neonatal Abstinence Syndrome

$810,655
Gary A Peltz · Stanford University · R01 · FY2016 · HD

Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents

$810,475
Terrence Burke · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Functional high-throughput contractility assay suite to develop therapeutics for asthma andhypertension

$810,473
Ivan Pushkarsky · Forcyte Biotechnologies, Inc. · R44 · FY2020 · TR

Nano-scale proteomic analysis: development, implementation, and applications

$810,420
Jinqiu Chen · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA

In Vitro Core

$810,360
Michael A Hoffman · University Of Wisconsin-Madison · U19 · FY2015 · AI